2023年7月3日

我寫關於醫療業務和政策得到它!蓋蒂不斷上升的醫療成本達到健康保險公司股票最近但這些多元化的公司應該很好。進入財報季聯合健康集團這樣的公司時,健康Elevance信諾,Centene,胡瑪納和CVS健康,安泰的父母,他們的第二季度利潤報告,有些人看到一些不太熟悉的不利因素:不斷上漲的醫療費用和客戶的損失。整個Covid-19大流行,許多健康保險公司公布了創紀錄的利潤,部分是因為美國人沒有使用該係統在2020年封鎖之前。當人們不去看醫生,聲稱不是向健康計劃所以保險公司更多的錢。更重要的是,美國突發公共衛生事件保持記錄的人被不踢任何人從醫療補助覆蓋拜登在國會和政府增加和擴大補貼更多的美國人負擔個人奧巴馬醫改覆蓋下的可支付醫療法案。這些趨勢幫助大多數醫療保險公司實現創紀錄的利潤。例如,聯合健康集團贏得了206億美元的淨利潤2022年賺173億美元在2021年和154億年的2020美元。在大流行聯合健康在2019年賺了138億美元。該公司經營健康保險公司UnitedHealthcare和醫療保健提供者服務業務,為聯合健康集團有望比去年更多。 UnitedHealth, which made $5.6 billion in the first quarter of this year, reports second quarter earnings on July 14. But things are beginning to change now, which some see as a threat to health insurance company bottom lines the insurer’s have been familiar with given the end in May of the U.S. public health emergency that boosted the number of Americans covered when Medicaid redetermination temporarily ended three years ago. Medicaid redetermination, also described as Medicaid renewal or Medicaid recertification, is essentially when people are asked to show they are qualified for such coverage. MORE FOR YOU Some states are beginning the Medicaid redetermination process as part of the U.S. public health emergency ends, but the process could take several months to a year or longer. The process is expected to impact health insurers like Centene that have a significant business administering Medicaid coverage for states. But analysts believe health insurers have what it takes to weather the storm of higher costs from increased health system usage and the introduction of more expensive drugs. “U.S. health insurers have adequate ratings headroom to withstand the mounting cost pressures driven by growing drug shortages, rising pharmaceutical and other input costs as well as higher utilization,” Fitch Ratings said in a report last month. “The structural advantages afforded to health insurers within the broader healthcare system, business model diversification and stable key financial metrics are key drivers supporting credit profiles.” To be sure, CVS and UnitedHealth, in particular, have been gobbling up providers of medical care, spending billions of dollars to grow their health services and networks of doctors and outpatient care operations. This should increase revenue to these large healthcare conglomerates on the medical care provider side of the business even as expenses rise on the insurance side of the business. Health insurers also have an advantage of higher rate increases they’ve already requested from their clients, including employers and governments. And some analysts think the federal government’s rate increase for Medicare Advantage plans is enough to help these insurers weather any increase in costs for that growing business. “Humana is raising 2023 MLR guidance to the high-end of the range due to elevated utilization,” Mizuho Americas analyst Ann Hynes said last month about Humana’s medical-loss ratio, which measures medical costs of health insurers. “(Humana) is reiterating 2023E adjusted EPS guidance, but the MLR headwind will likely limit upside going forward. Importantly, Humana stated that the elevated utilization was contemplated in 2024 Medicare Advantage bids submitted earlier this month, which should relieve some investor fears.” Follow me on Twitter or LinkedIn . Check out my website or some of my other work here .